Evidence map›Paper›PMID 26668063›Full record

ArticleClinical and translational medicine2015

Benchmarks for ethically credible partnerships between industry and academic health centers: beyond disclosure of financial conflicts of interest.

Eric M Meslin, Joshua B Rager, Peter H Schwartz, Kimberly A Quaid, Margaret M Gaffney, Jon Duke, William H Tierney

Erratum issuedAbstract read
In one paragraph

Article in Clinical and translational medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Eric M MeslinIndiana University Center for Bioethics, 410 West 10th Street, Indianapolis, IN, 46202, USA. emeslin@iu.edu.
Joshua B RagerIndiana University Center for Bioethics, 410 West 10th Street, Indianapolis, IN, 46202, USA. jbrager@iupui.edu.
Peter H SchwartzIndiana University Center for Bioethics, 410 West 10th Street, Indianapolis, IN, 46202, USA. phschwar@iu.edu.
Kimberly A QuaidIndiana University Center for Bioethics, 410 West 10th Street, Indianapolis, IN, 46202, USA. kquaid@iu.edu.
Margaret M GaffneyIndiana University Center for Bioethics, 410 West 10th Street, Indianapolis, IN, 46202, USA. mgaffney@iupui.edu.
Jon DukeRegenstrief Institute Inc., 410 West 10th Street, Indianapolis, IN, 46202, USA. jonduke@regenstrief.org.
William H TierneyRegenstrief Institute Inc., 410 West 10th Street, Indianapolis, IN, 46202, USA. wtierney@iupui.edu.

Funding

Quality Assurance and Quality Control Project Management: Improving Submissions and Study Conduct in the Human Subjects Research Prior Approval ProcessUL1TR002529 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI MOE, SHARON M, WIEHE, SARAH ELIZABETH · 2018 to 2022
$27.2M
Indiana Clinical and Translational Sciences InstituteUL1TR001108 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI DENNE, SCOTT C., SHEKHAR, ANANTHA · 2013 to 2017
$23.3M
Indiana University-Moi University Academic Research Ethics PartnershipR25TW006070 · FIC · INDIANA UNIVERSITY INDIANAPOLIS · PI VREEMAN, RACHEL CHRISTINE · 2008 to 2016
$2.2M
FIC NIH HHS R25 TW006070NCATS NIH HHS UL1 TR001108
6 · The paper itself

Abstract

Relationships between industry and university-based researchers have been commonplace for decades and have received notable attention concerning the conflicts of interest these relationships may harbor. While new efforts are being made to update conflict of interest policies and make industry relationships with academia more transparent, the development of broader institutional partnerships between industry and academic health centers challenges the efficacy of current policy to effectively manage these innovative partnerships. In this paper, we argue that existing strategies to reduce conflicts of interest are not sufficient to address the emerging models of industry-academic partnerships because they focus too narrowly on financial matters and are not comprehensive enough to mitigate all ethical risk. Moreover, conflict-of-interest strategies are not designed to promote best practices nor the scientific and social benefits of academic-industry collaboration. We propose a framework of principles and benchmarks for "ethically credible partnerships" between industry and academic health centers and describe how this framework may provide a practical and comprehensive approach for designing and evaluating such partnerships.

Indexed as

Academic health centersAcademic-industry partnershipsAcademic-industry relationshipsBenchmarksCollaborationConflict of interestCooperative behaviorEthicsIndustry

Identifiers

PMID26668063
PMCPMC4678144

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.